123 related articles for article (PubMed ID: 34751446)
21. Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma.
Li Y; Chen CQ; He YL; Cai SR; Yang DJ; He WL; Xu JB; Zan WH
J Surg Oncol; 2012 Sep; 106(3):304-10. PubMed ID: 22231933
[TBL] [Abstract][Full Text] [Related]
22. Impact of the anatomical location and the number of metastatic lymph nodes on gastric cancer patient´s survival.
Duchon R; Bernadic M; Pindak D
Bratisl Lek Listy; 2020; 121(4):253-258. PubMed ID: 32356438
[TBL] [Abstract][Full Text] [Related]
23. CD44V6 in gastric carcinoma: a marker of tumor progression.
Xin Y; Grace A; Gallagher MM; Curran BT; Leader MB; Kay EW
Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):138-42. PubMed ID: 11396631
[TBL] [Abstract][Full Text] [Related]
24. CD44 and CD44v6 are Correlated with Gastric Cancer Progression and Poor Patient Prognosis: Evidence from 42 Studies.
Fang M; Wu J; Lai X; Ai H; Tao Y; Zhu B; Huang L
Cell Physiol Biochem; 2016; 40(3-4):567-578. PubMed ID: 27889771
[TBL] [Abstract][Full Text] [Related]
25. The Poor Prognosis of Patients with Stage III Gastric Cancer after D2 Dissection Is Mainly due to Lymphatic Metastasis, Especially the Metastasis of No.12a LN: A Nested Case-Control Study.
Huang X; Liu H; Hu Y; Yu J; Liao X; Li G
Oncol Res Treat; 2021; 44(6):313-321. PubMed ID: 33946083
[TBL] [Abstract][Full Text] [Related]
26. E-cadherin in gastric carcinomas: Relations with histological parameters and its prognostic value.
Schizas D; Moris D; Michalinos A; Kanavidis P; Oikonomou D; Papalampros A; Machairas A; Liakakos T
J BUON; 2017; 22(2):383-389. PubMed ID: 28534359
[TBL] [Abstract][Full Text] [Related]
27. Towards standardization of lymph-node ratio classifications: Validation and comparison of different lymph node ratio classifications for predicting prognosis of patients with resected gastric cancer.
Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
Ann Diagn Pathol; 2021 Jun; 52():151738. PubMed ID: 33865185
[TBL] [Abstract][Full Text] [Related]
28. The significances of lymph node micrometastasis and its correlation with E-cadherin expression in pT1-T3N0 gastric adenocarcinoma.
Kim JH; Park JM; Jung CW; Park SS; Kim SJ; Mok YJ; Kim CS; Chae YS; Bae JW
J Surg Oncol; 2008 Feb; 97(2):125-30. PubMed ID: 18095267
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
30. Topographic lymph node staging system shows prognostic superiority compared to the 8th edition of AJCC TNM in gastric cancer. A western monocentric experience.
Lauricella S; Caricato M; Mascianà G; Carannante F; Carnazza M; Bonaccorso A; Angeletti S; Ciccozzi M; Coppola R; Capolupo GT
Surg Oncol; 2020 Sep; 34():223-233. PubMed ID: 32869748
[TBL] [Abstract][Full Text] [Related]
31. [Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
Wu H; Wang L; He YL; Xu JB; Cai SR; Ma JP; Chen CQ; Zhang XH; Zhan WH
Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):509-13. PubMed ID: 24257302
[TBL] [Abstract][Full Text] [Related]
32. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
33. Analysis of a cytoskeleton-associated kinase PEAK1 and E-cadherin in gastric cancer.
Guo Q; Qin W; Li B; Yang H; Guan J; Liu Z; Li S
Pathol Res Pract; 2014 Dec; 210(12):793-8. PubMed ID: 25445115
[TBL] [Abstract][Full Text] [Related]
34. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
[TBL] [Abstract][Full Text] [Related]
35. The clinicopathological characteristics and prognosis of patients with node-positive gastric cancer after curative surgery.
Lum CY; Huang KH; Chen MH; Fang WL; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM
J Chin Med Assoc; 2020 Aug; 83(8):751-755. PubMed ID: 32349036
[TBL] [Abstract][Full Text] [Related]
36. CD44V6 regulates gastric carcinoma occurrence and development through up-regulating VEGF expression.
Liang S; Li HL; Han GY; Cui JH
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5121-5128. PubMed ID: 29228423
[TBL] [Abstract][Full Text] [Related]
37. Nomogram Incorporating CD44v6 and Clinicopathological Factors to Predict Lymph Node Metastasis for Early Gastric Cancer.
Eom BW; Joo J; Park B; Jo MJ; Choi SH; Cho SJ; Ryu KW; Kim YW; Kook MC
PLoS One; 2016; 11(8):e0159424. PubMed ID: 27482895
[TBL] [Abstract][Full Text] [Related]
38. Survival after resection of gastric cancer and prognostic relevance of systematic lymph node dissection: twenty years experience in Taiwan.
Lee WJ; Lee WC; Houng SJ; Shun CT; Houng RL; Lee PH; Chang KJ; Wei TC; Chen KM
World J Surg; 1995; 19(5):707-13. PubMed ID: 7571667
[TBL] [Abstract][Full Text] [Related]
39. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer.
Eom BW; Joo J; Kim YW; Reim D; Park JY; Yoon HM; Ryu KW; Lee JY; Kook MC
Surgery; 2014 Mar; 155(3):408-16. PubMed ID: 24287148
[TBL] [Abstract][Full Text] [Related]
40. Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stage.
Schwarz RE; Smith DD
Ann Surg Oncol; 2007 Feb; 14(2):317-28. PubMed ID: 17094022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
